Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

COVID-19 update: CDC panel recommends Pfizer booster shot for some

By Yvonne Puig (US), Daphne Calderon (US) & Hannah Putnam (US) on September 23, 2021
Email this postTweet this postLike this postShare this post on LinkedIn

On September 23, 2021, a panel of experts from the CDC, the Advisory Committee on Immunization Practice (“ACIP”), recommended that three categories of people should receive a COVID-19 booster shot: (1) those aged 65 and older; (2) those in long-term care residencies; and (3) those over 18 with underlying medical conditions. ACIP members voted unanimously for the first two categories of people who should receive booster vaccines. The panel was more divided with regard to the third category, however, with only nine of the fifteen members voting in favor of booster shots for individuals over 18 who are more at risk of severe reactions to COVID-19 due to underlying medical conditions.

This recommendation from the ACIP came just one day after the FDA approved Pfizer’s EUA application for administering booster shots for individuals in similar categories. The CDC’s website states that COVID-19 booster vaccines will not be immediately available and that individuals are only eligible to receive a booster shot eight months after receiving the last series of the vaccine. ACIP’s recommendations are just that—recommendations; CDC Director Dr. Rochelle Walensky must choose whether to adopt or overrule the recommendation, which she has not done at this time.

Norton Rose Fulbright lawyers will continue to provide relevant updates for healthcare providers on the Health Law Pulse during the COVID-19 public health crisis.

Photo of Yvonne Puig (US) Yvonne Puig (US)

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in…

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in Norton Rose Fulbright’s Austin office, Yvonne’s practice involves commercial and health care litigation, antitrust, regulatory and compliance advice, crisis management, staff privileges, exclusive contracting and administrative law.

Read more about Yvonne Puig (US)Email
Show more Show less
Photo of Daphne Calderon (US) Daphne Calderon (US)
Read more about Daphne Calderon (US)Email
Photo of Hannah Putnam (US) Hannah Putnam (US)
Read more about Hannah Putnam (US)Email
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Health Law Pulse
  • Organization:
    Norton Rose Fulbright
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo